KPC Pharmaceuticals, Inc. (600422.SS) SHH

Currency In CNY

AD

Valuation

Market Cap9.55B
Enterprise Value10.43B
P/E Ratio-22.69
PEG Ratio0.18
Price/Sales Ratio1.44
Price/Book Ratio1.35
Enterprise/Revenue1.69
Enterprise/EBITDA-29.24

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin-0.06
Operating Margin-0.09
AD

Management Effectiveness

Return On Assets-0.03
Return On Equity-0.06

Income Statement

Revenue6.58B
Revenue/Share6.01
Gross Profit2.53B
EBITDA674.39M
Net Income349.94M
Diluted EPS0.46

Balance Sheet

Total Cash1.37B
Total Cash/Share1.81
Total Debt1.82B
Total Debt/Equity0.37
Current Ratio2.11
Book Value Per Share8.51

Price History

52-Week Change-37.91
52-Week High14.05
52-Week Low7.45
Moving Average 50 Days8.42
Moving Average 200 Days9.59

Statistics

Average Volume8.47M
Shares Outstanding756.98M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.18
Trailing Annual Dividend Yield2.07
Payout Ratio-0.64
Last Split Factor2:1
Last Split DateMay 09, 2016
AD